Megakaryocyte c-Mpl expression in chronic myeloproliferative disorders and the myelodysplastic syndrome: Immunoperoxidase staining patterns and clinical correlates

Soo-Young Yoon, Chin Yang Li, Ayalew Tefferi

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The objectives of this study were to expand on recent observations that have suggested decreased thrombopoietin receptor (c-Mpl) expression in megakaryocytes of patients with polycythemia vera (PV) and agnogenic myeloid metaplasia (AMM). We applied an immunoperoxidase method with anti-c-Mpl antibody to 55 bone marrow sections from previously untreated patients with chronic myeloproliferative disorder (CMPD) or myelodysplastic syndrome (MDS). These included 8 patients with PV, 15 with AMM, 9 with essential thrombocythemia, 5 with chronic myelocytic leukemia, 9 with the 5q - syndrome and 9 with MDS with fibrosis. The findings were compared with those in four patients with reactive erythrocytosis (RE), six with immune thrombocytopenic purpura (ITP) and five normal controls. Staining intensity (SI) was moderate to strong both in normal controls and in patients with RE or ITP. In contrast, SI was weak in variable proportions of the megakaryocytes in every one of the aforementioned clonal myeloid disorders. The staining pattern (SP) was relatively uniform in MDS and heterogeneous in CMPD. Neither SI nor SP was significantly correlated with certain clinical or laboratory parameters. We concluded that altered megakaryocyte c-Mpl expression may be a nonspecific phenomenon in various subtypes of both CMPD and MDS. However, the characteristic staining patterns may complement the morphological distinction between clonal and reactive myeloproliferation.

Original languageEnglish
Pages (from-to)170-174
Number of pages5
JournalEuropean Journal of Haematology
Volume65
Issue number3
DOIs
Publication statusPublished - 2000 Sep 20

Fingerprint

Myeloproliferative Disorders
Megakaryocytes
Myelodysplastic Syndromes
Staining and Labeling
Polycythemia Vera
Polycythemia
Primary Myelofibrosis
Idiopathic Thrombocytopenic Purpura
Thrombopoietin Receptors
Essential Thrombocythemia
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Fibrosis
Bone Marrow

Keywords

  • c-Mpl
  • Chronic myeloproliferative disorders
  • Immunoperoxidase
  • Megakaryocyte
  • Myelodysplastic syndrome
  • Thrombopoietin receptor

ASJC Scopus subject areas

  • Hematology

Cite this

@article{3cd5be0deb6948989a0304a975b07380,
title = "Megakaryocyte c-Mpl expression in chronic myeloproliferative disorders and the myelodysplastic syndrome: Immunoperoxidase staining patterns and clinical correlates",
abstract = "The objectives of this study were to expand on recent observations that have suggested decreased thrombopoietin receptor (c-Mpl) expression in megakaryocytes of patients with polycythemia vera (PV) and agnogenic myeloid metaplasia (AMM). We applied an immunoperoxidase method with anti-c-Mpl antibody to 55 bone marrow sections from previously untreated patients with chronic myeloproliferative disorder (CMPD) or myelodysplastic syndrome (MDS). These included 8 patients with PV, 15 with AMM, 9 with essential thrombocythemia, 5 with chronic myelocytic leukemia, 9 with the 5q - syndrome and 9 with MDS with fibrosis. The findings were compared with those in four patients with reactive erythrocytosis (RE), six with immune thrombocytopenic purpura (ITP) and five normal controls. Staining intensity (SI) was moderate to strong both in normal controls and in patients with RE or ITP. In contrast, SI was weak in variable proportions of the megakaryocytes in every one of the aforementioned clonal myeloid disorders. The staining pattern (SP) was relatively uniform in MDS and heterogeneous in CMPD. Neither SI nor SP was significantly correlated with certain clinical or laboratory parameters. We concluded that altered megakaryocyte c-Mpl expression may be a nonspecific phenomenon in various subtypes of both CMPD and MDS. However, the characteristic staining patterns may complement the morphological distinction between clonal and reactive myeloproliferation.",
keywords = "c-Mpl, Chronic myeloproliferative disorders, Immunoperoxidase, Megakaryocyte, Myelodysplastic syndrome, Thrombopoietin receptor",
author = "Soo-Young Yoon and Li, {Chin Yang} and Ayalew Tefferi",
year = "2000",
month = "9",
day = "20",
doi = "10.1034/j.1600-0609.2000.90235.x",
language = "English",
volume = "65",
pages = "170--174",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Megakaryocyte c-Mpl expression in chronic myeloproliferative disorders and the myelodysplastic syndrome

T2 - Immunoperoxidase staining patterns and clinical correlates

AU - Yoon, Soo-Young

AU - Li, Chin Yang

AU - Tefferi, Ayalew

PY - 2000/9/20

Y1 - 2000/9/20

N2 - The objectives of this study were to expand on recent observations that have suggested decreased thrombopoietin receptor (c-Mpl) expression in megakaryocytes of patients with polycythemia vera (PV) and agnogenic myeloid metaplasia (AMM). We applied an immunoperoxidase method with anti-c-Mpl antibody to 55 bone marrow sections from previously untreated patients with chronic myeloproliferative disorder (CMPD) or myelodysplastic syndrome (MDS). These included 8 patients with PV, 15 with AMM, 9 with essential thrombocythemia, 5 with chronic myelocytic leukemia, 9 with the 5q - syndrome and 9 with MDS with fibrosis. The findings were compared with those in four patients with reactive erythrocytosis (RE), six with immune thrombocytopenic purpura (ITP) and five normal controls. Staining intensity (SI) was moderate to strong both in normal controls and in patients with RE or ITP. In contrast, SI was weak in variable proportions of the megakaryocytes in every one of the aforementioned clonal myeloid disorders. The staining pattern (SP) was relatively uniform in MDS and heterogeneous in CMPD. Neither SI nor SP was significantly correlated with certain clinical or laboratory parameters. We concluded that altered megakaryocyte c-Mpl expression may be a nonspecific phenomenon in various subtypes of both CMPD and MDS. However, the characteristic staining patterns may complement the morphological distinction between clonal and reactive myeloproliferation.

AB - The objectives of this study were to expand on recent observations that have suggested decreased thrombopoietin receptor (c-Mpl) expression in megakaryocytes of patients with polycythemia vera (PV) and agnogenic myeloid metaplasia (AMM). We applied an immunoperoxidase method with anti-c-Mpl antibody to 55 bone marrow sections from previously untreated patients with chronic myeloproliferative disorder (CMPD) or myelodysplastic syndrome (MDS). These included 8 patients with PV, 15 with AMM, 9 with essential thrombocythemia, 5 with chronic myelocytic leukemia, 9 with the 5q - syndrome and 9 with MDS with fibrosis. The findings were compared with those in four patients with reactive erythrocytosis (RE), six with immune thrombocytopenic purpura (ITP) and five normal controls. Staining intensity (SI) was moderate to strong both in normal controls and in patients with RE or ITP. In contrast, SI was weak in variable proportions of the megakaryocytes in every one of the aforementioned clonal myeloid disorders. The staining pattern (SP) was relatively uniform in MDS and heterogeneous in CMPD. Neither SI nor SP was significantly correlated with certain clinical or laboratory parameters. We concluded that altered megakaryocyte c-Mpl expression may be a nonspecific phenomenon in various subtypes of both CMPD and MDS. However, the characteristic staining patterns may complement the morphological distinction between clonal and reactive myeloproliferation.

KW - c-Mpl

KW - Chronic myeloproliferative disorders

KW - Immunoperoxidase

KW - Megakaryocyte

KW - Myelodysplastic syndrome

KW - Thrombopoietin receptor

UR - http://www.scopus.com/inward/record.url?scp=0033857243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033857243&partnerID=8YFLogxK

U2 - 10.1034/j.1600-0609.2000.90235.x

DO - 10.1034/j.1600-0609.2000.90235.x

M3 - Article

C2 - 11007052

AN - SCOPUS:0033857243

VL - 65

SP - 170

EP - 174

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 3

ER -